Halozyme Therapeutics HALO
NASDAQ HALO
$110.43 -1.13 (-1.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Halozyme Therapeutics (HALO) Enterprise Value (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Enterprise Value of $8.7 billion for Q2 2026, up 56.1% from $5.57 billion a year earlier and up 18.4% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Enterprise Value (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Halozyme Therapeutics was $7.53 billion, up 111.6% year-over-year; for FY2025, it came in at $7.78 billion, up 47.1% from FY2024.

  • Annual Enterprise Value shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
  • In prior years, Halozyme Therapeutics' Enterprise Value was $5.29 billion in FY2024 (+21.7%), $4.35 billion in FY2023 (-40.6%), $7.33 billion in FY2022 (+52.5%) and $4.8 billion in FY2021 (-12.2%).
  • The Q2 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q2 2010.
  • On a year-over-year basis, Enterprise Value has increased in each of the last four quarters, with growth averaging 29.4% over the last eight quarters.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2026, with growth of 56.1%; the weakest was Q4 2023, with a decline of 40.6%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $7.34 billion (Q1 2026), $7.78 billion (Q4 2025) and $7.92 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Halozyme Therapeutics 12.72 Bn 11.33 Bn 401.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.70 Bn
Mar 31, 2026 7.34 Bn
Dec 31, 2025 7.78 Bn
Sep 30, 2025 7.92 Bn
Jun 30, 2025 5.57 Bn
Mar 31, 2025 7.11 Bn
Dec 31, 2024 5.29 Bn
Sep 30, 2024 6.61 Bn
Jun 30, 2024 6.10 Bn
Mar 31, 2024 4.71 Bn
Dec 31, 2023 4.35 Bn
Sep 30, 2023 4.56 Bn
Jun 30, 2023 4.41 Bn
Mar 31, 2023 4.75 Bn
Dec 31, 2022 7.33 Bn
Sep 30, 2022 5.08 Bn
Jun 30, 2022 5.85 Bn
Mar 31, 2022 4.71 Bn
Dec 31, 2021 4.80 Bn
Sep 30, 2021 4.92 Bn
API Access

Halozyme Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=HALO&period=max&api_key=YOUR_API_KEY